Rajesh Malik is Director of POINT Biopharma Global Inc.. Currently has a direct ownership of 0 shares of PNT, which is worth approximately $0. The most recent transaction as insider was on Dec 26, 2023, when has been sold 3,700 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Rajesh Malik Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 26 2023
SELL
Disposition due to a tender of shares in a change of control transaction
-
3,700 Reduced 100.0%
0 Common Stock
Nov 28 2022
BUY
Open market or private purchase
$24,642 $6.66 p/Share
3,700 Added 50.0%
3,700 Common Stock

Also insider at

GTHX
G1 Therapeutics, Inc. Healthcare
RM

Rajesh Malik

Director
Research Triangle Park, NC

Track Institutional and Insider Activities on PNT

Follow POINT Biopharma Global Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PNT shares.

Notify only if

Insider Trading

Get notified when an Point Biopharma Global Inc. insider buys or sells PNT shares.

Notify only if

News

Receive news related to POINT Biopharma Global Inc.

Track Activities on PNT